On January 1, the prices of more than 1,200 medications available in pharmacies, thanks to the entry into force of the Reference Price Order of 2018, published in the Official State Gazette (BOE) on November 27.
This drop in prices, as recalled by the General Council of Official Associations of Pharmacists, will reduce the public bill for medicines by 88 million euros. In addition, 497 presentations of hospital medications will also be priced.
Among the medicines that will reduce the price are anti-inflammatory, antitussive, or drugs for arthrosis, hypercholesterolemia, glaucoma or high blood pressure. Thus, ten active ingredients with the greatest impact on the price reduction, they represent 89 percent of the reduction of the bill.
In addition, among the presentations of medicines that lower the price in the community pharmacy are active ingredients such as ibuprofen, drugs for asthma such as salbutamol or budesonide, antidepressants such as escitalopram, oral contraceptives such as levonorgestrel / ethinylestradiol or drugs for Parkinson's such as ropinirole.
Since it was published on November 27 this order that has affected More than 16,000 presentations of medicines, and until next January 1, pharmacies have been dispensing available stocks at the previous price. As of Tuesday, with the entry into force of the new prices, pharmacies will dispense the drugs at a reduced price, assuming the difference of the stocks that are still in stock.
"The reference price system has been consolidated, however we believe that, once the savings have been passed, some aspects that harm the pharmacy should be corrected beyond the reduction in billing, for example, extend the coexistence of medicines with old and new prices", said the president of the General Council of Official Associations of Pharmacists, Jesús Aguilar.